GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Enovis Corp (NYSE:ENOV) » Definitions » Cyclically Adjusted PS Ratio

Enovis (Enovis) Cyclically Adjusted PS Ratio : 0.77 (As of Apr. 28, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Enovis Cyclically Adjusted PS Ratio?

As of today (2024-04-28), Enovis's current share price is $55.26. Enovis's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $71.69. Enovis's Cyclically Adjusted PS Ratio for today is 0.77.

The historical rank and industry rank for Enovis's Cyclically Adjusted PS Ratio or its related term are showing as below:

ENOV' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.32   Med: 0.7   Max: 1.03
Current: 0.77

During the past years, Enovis's highest Cyclically Adjusted PS Ratio was 1.03. The lowest was 0.32. And the median was 0.70.

ENOV's Cyclically Adjusted PS Ratio is ranked better than
68.91% of 2152 companies
in the Industrial Products industry
Industry Median: 1.405 vs ENOV: 0.77

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Enovis's adjusted revenue per share data for the three months ended in Dec. 2023 was $8.335. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $71.69 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Enovis Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Enovis's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enovis Cyclically Adjusted PS Ratio Chart

Enovis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.73 0.77 0.88 0.66 0.78

Enovis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.67 0.83 0.70 0.78

Competitive Comparison of Enovis's Cyclically Adjusted PS Ratio

For the Specialty Industrial Machinery subindustry, Enovis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enovis's Cyclically Adjusted PS Ratio Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Enovis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Enovis's Cyclically Adjusted PS Ratio falls into.



Enovis Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Enovis's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=55.26/71.69
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enovis's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Enovis's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=8.335/129.4194*129.4194
=8.335

Current CPI (Dec. 2023) = 129.4194.

Enovis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 27.722 99.695 35.988
201406 28.673 100.560 36.902
201409 27.862 100.428 35.905
201412 28.870 99.070 37.714
201503 21.849 99.621 28.384
201506 24.558 100.684 31.567
201509 23.254 100.392 29.978
201512 12.785 99.792 16.581
201603 21.344 100.470 27.494
201606 23.341 101.688 29.706
201609 18.680 101.861 23.734
201612 19.750 101.863 25.093
201703 17.779 102.862 22.369
201706 20.523 103.349 25.700
201709 20.418 104.136 25.375
201712 -11.813 104.011 -14.699
201803 21.299 105.290 26.180
201806 13.682 106.317 16.655
201809 13.271 106.507 16.126
201812 14.645 105.998 17.881
201903 15.344 107.251 18.516
201906 19.906 108.070 23.839
201909 18.530 108.329 22.137
201912 18.990 108.420 22.668
202003 17.311 108.902 20.573
202006 13.609 108.767 16.193
202009 17.509 109.815 20.635
202012 -24.591 109.897 -28.959
202103 18.605 111.754 21.546
202106 6.943 114.631 7.839
202109 6.787 115.734 7.590
202112 7.425 117.630 8.169
202203 6.969 121.301 7.435
202206 7.247 125.017 7.502
202209 7.090 125.227 7.327
202212 7.543 125.222 7.796
202303 7.476 127.348 7.598
202306 7.861 128.729 7.903
202309 7.654 129.860 7.628
202312 8.335 129.419 8.335

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Enovis  (NYSE:ENOV) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Enovis Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Enovis's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Enovis (Enovis) Business Description

Traded in Other Exchanges
Address
2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy.. The company conducts its operations through two operating segments: Prevention & Recovery ("P&R") and Reconstructive ("Recon"). It generates majority revenue form Prevention & Recovery segment.
Executives
John Kleckner officer: Principal Accounting Officer 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Berry Phillip Benjamin (ben) officer: SVP, Chief Financial Officer 2711 CENTERVILLE ROAD SUITE 400, WILMINGTON DE 19808
Rajiv Vinnakota director 8730 STONY POINT PARKWAY, SUITE 150, RICHMOND VA 23235
A Clayton Perfall director
Brady Shirley officer: EVP, Colfax, Pres. & CEO, DJO 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Patricia A Lang officer: SVP, Chief HR Officer C/O DIEBOLD NIXDORF, INCORPORATED, 5995 MAYFAIR ROAD, NORTH CANTON OH 44720
Bradley J Tandy officer: SVP, General Counsel P.O. BOX 587, 56 E. BELL DRIVE, WARSAW IN 46580
Daniel A Pryor officer: SVP??Strategy & Business Deve. DANAHER CORP, 2099 PENNSYLVANIA AVE NW 12TH FL, WASHINGTON DC 20006
Matthew L. Trerotola director, officer: President & CEO 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Christopher M Hix officer: SVP, Chief Financial Officer 2160 SATELLITE BLVD., SUITE 200, DULUTH GA 30097
Barbara W. Bodem director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Christine Ortiz director 1200 ABERNATHY ROAD, NE, SUITE 1200, ATLANTA GA 30328
Angela S Lalor director 3M CENTER, BLDG. 0220-09-E-02, ST PAUL MN 55144 1000
Shyam Kambeyanda officer: ESAB President and SVP, Colfax 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Douglas J. Pitts officer: Controller, PAO 100 MATSONFORD ROAD, RADNOR PA 19087